The treatment of cocaine use disorder
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Psychosocial/behavioral interventions-such as contingency management, community reinforcement, and cognitive behavioral therapy -remain the standard and most reliably available practices for treatment of MUD (36) and CUD (37).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contingency management for treatment of substance use disorders: a meta‐analysis
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01581.x · Cited by 877
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
Self-citationScofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 545
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
Give them prizes and they will come: Contingency management for treatment of alcohol dependence.
Petry, N. M., Martin, B., Cooney, J. L., & Kranzler, H. R. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.250 · Cited by 515
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120061010 · Cited by 409
Carroll, K. M., Ball, S. A., Martino, S., Nich, C., Babuscio, T. A., Nuro, K. F., Gordon, M. A., Portnoy, G. A., & Rounsaville, B. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111835 · Cited by 405
Cited by
Items 101–200 of 286
D-amphetamine maintenance therapy reduces cocaine use in female rats
Ndiaye, N. A., Allain, F., & Samaha, A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06271-w · Cited by 6
Evidence of Hypothalamic-Pituitary-Adrenal and -Gonadal Dysfunction in Cocaine-Addicted Men
Ersche, K. D., Štochl, J., Brühl, A. B., & Gurnell, M. (2024) · European Addiction Research · doi:10.1159/000535584 · Cited by 6
Comprehensive Management of Cocaine-Induced Midline Destructive Lesions: A Young-IfOS Consensus
Saibene, A. M., Nitro, L., Carsuzaa, F., Alexandru, M., Bedarida, V., Bari, M. D., Fath, L., García‐Lliberós, A., Legré, M., Lobo, D., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15060231 · Cited by 5
Rough, M. I., & Nader, M. A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100119 · Cited by 5
Brain systems in cocaine abstinence-induced anxiety-like behavior in rodents: A review
Barbee, B. R., & Gourley, S. L. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100012 · Cited by 5
Winters, A. D., Francescutti, D. M., Kracht, D. J., Chaudhari, D. S., Zagorac, B., & Angoa‐Pérez, M. (2025) · Microorganisms · doi:10.3390/microorganisms13010077 · Cited by 5
The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review
Powell, A., Yamaguchi, N., Lu, H., Pareek, O., Elman, I., Gold, M. S., Pinhasov, A., Blum, K., & Thanos, P. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26812 · Cited by 5
Perceived need for drug treatment among African American male drug-using prisoners
Dogan, J. N., Stevens-Watkins, D. J., Knighton, J.-S., Wheeler, P. B., & Hargons, C. N. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108166 · Cited by 5
Votaw, V. R., Tuchman, F. R., Roos, C. R., Hebden, H. M., McKay, J. R., Kiluk, B. D., & Witkiewitz, K. A. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209394 · Cited by 5
Allen, M. I., Costa, M. B., Johnson, B., Gould, R. W., & Nader, M. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01882-7 · Cited by 5
Tang, Q., Li, Z., Zhang, F., Han, L., & Pu, W. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111094 · Cited by 5
Cocaine-induced Movement Disorder: A Literature Review
Byroju, V. V., Rissardo, J. P., Durante, Í., & Caprara, A. L. F. (2024) · Prague Medical Report · doi:10.14712/23362936.2024.19 · Cited by 5
Gaulden, A. D., Tepe, E. A., Sia, E., Rollins, S. S., & McReynolds, J. R. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114840 · Cited by 5
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells
Rossi, L., Pierigè, F., Agostini, M., Bigini, N., Termopoli, V., Cai, Y., Zheng, F., Zhan, C., Landry, D. W., & Magnani, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.573492 · Cited by 5
Emerson, S., Hay, M., Smith, M., Granger, R., Blauch, D. N., Snyder, N. L., & Bejjani, R. M. E. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab143 · Cited by 5
Tschudi, L., Fischer, S. K. M., Perlov, E., Baumgartner, M. R., Soyka, M., Müller, T., Seifritz, E., & Mutschler, J. (2023) · European Addiction Research · doi:10.1159/000531008 · Cited by 5
Maahs, S., Leclair, D., Gomez‐Mancilla, B., Kiluk, B. D., Muthusamy, V. S., Banerjee, P. S., Dasgupta, S., & Waye, K. M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1230699 · Cited by 5
Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/− mice
Cabana‐Domínguez, J., Martín‐García, E., Gallego-Román, A., Maldonado, R. J., Fernàndez‐Castillo, N., & Cormand, B. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01396-6 · Cited by 5
Luján, M. Á., Alegre-Zurano, L., Martín‐Sánchez, A., & Valverde, O. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.23.916601 · Cited by 5
Histone Deacetylase 5 in Prelimbic Prefrontal Cortex Limits Context-Associated Cocaine Seeking
Barry, S. M., Huebschman, J. L., DeVries, D. M., McCue, L. M., Tsvetkov, E., Akiki, R. M., Limbaker, C., Anderson, E. M., Wood, D. J., Siemsen, B. M., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.027 · Cited by 4
Berry, M., Miller, B., Kelsen, S., Cockrell, C., & Kohtz, A. S. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1379866 · Cited by 4
Pérez, L. J. G., Cardullo, S., Zaffaina, G. C., Cuppone, D., Chindamo, S., Zattin, A., Cellini, N., Terraneo, A., & Gallimberti, L. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209706 · Cited by 5
Disorders due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_26 · Cited by 4
Bórquez, I., Krawczyk, N., Matthay, E. C., Charris, R., Dupré, S., Piñones, M. M., Carvacho, P., Cerdá, M., Castillo‐Carniglia, Á., & Valenzuela, E. (2025) · Addiction · doi:10.1111/add.16731 · Cited by 4
Greydanus, D. E., Nazeer, A., & Patel, D. R. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.101853 · Cited by 4
Stoops, W. W., Shellenberg, T., Regnier, S. D., Cox, D. H., Adatorwovor, R., Hays, L. R., Anderson, D. M., Lile, J. A., Schmitz, J. M., Havens, J. R., et al. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112642 · Cited by 4
Beckett, K. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780197536575.003.0008 · Cited by 4
Mallorquí‐Bagué, N., Palazón-Llecha, A., Madre, M., Batlle, F., Duran‐Sindreu, S., & Trujols, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1051528 · Cited by 4
β2* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats
Walker, N. B., Tucker, B. R., Thomas, L. N., Tapp, A. E., Neel, A. I., Chen, R., Jones, S. R., & Drenan, R. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109927 · Cited by 4
Freitas-Santos, J., Brito, I. R. R., de Melo, I. S., Oliveira, K. B., de Souza, F. M. A., Gitaí, D. L. G., Duzzioni, M., Bueno, N. B., de Araujo, L. A., Shetty, A. K., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111049 · Cited by 4
Haney, M., Rubin, E., Denson, R. K., & Foltin, R. W. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108554 · Cited by 4
Gómez, C. P., Langlade, J. P., & Gantiva, C. (2024) · Journal of Addictive Diseases · doi:10.1080/10550887.2024.2327762 · Cited by 3
Burlew, A. K., Ruglass, L. M., Espinosa, A., McCuistian, C. L., Haeny, A. M., Jordan, A., Roundtree, C., Lopez, J., Vena, A. A., & Morgan‐López, A. A. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112850 · Cited by 3
Zacher, A., Dietiker, L., Häffner, V., Bavato, F., Kleim, B., & Quednow, B. B. (2026) · Addiction · doi:10.1111/add.70449 · Cited by 3
Flores-López, M., García‐Marchena, N., Pavón, F. J., Requena-Ocaña, N., Sánchez‐Marín, L., Martín-Chaves, L., García-Medina, M., Pedraza, C., Castilla‐Ortega, E., Ruiz, J. J., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02523-1 · Cited by 3
Murphy, Z. D., Mulugeta, R., Tran, A., & Ferguson, S. M. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100122 · Cited by 3
Psychostimulant and opioid abuse: A perspective from Uruguay
Richeri, A., McGregor, R., & Scorza, C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.014 · Cited by 3
Marcus, M. M., & Banks, M. L. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106217 · Cited by 3
Jia, B., Wei, R., Li, Z., Feng, M., Wang, M., Zhao, C., Wei, Y., Liu, Z., & Hu, Y. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06075-5 · Cited by 3
Novel Pharmacological Agents for the Treatment of Cocaine Use Disorder
Hadizadeh, H., Flores, J. M., Nunes, E. J., Mayerson, T. F., Potenza, M. N., & Angarita, G. A. (2022) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-022-00246-z · Cited by 3
Further proof on the role of accumbal nNOS in cocaine-seeking behavior in rats
Frankowska, M., Smaga, I., Gawlińska, K., Pieniążek, R., & Filip, M. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00571-y · Cited by 3
Teague, C. D., Markovic, T., Zhou, X., Martínez-Rivera, F. J., Minier-Toribio, A. M., Zinsmaier, A. K., Pulido, N. V., Schmidt, K. H., Lucerne, K. E., Godino, A., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1327-23.2024 · Cited by 3
Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.
Schepis, T. S., Veliz, P. T., McCabe, V. V., Werner, K. S., Pasman, E., Wilens, T. E., & McCabe, S. E. (2025) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000761 · Cited by 3
Beckett, K. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780197536575.003.0001 · Cited by 3
Yin and Yang of Gut Microbiota in Cocaine Abuse
Baldi, S., Gerace, E., Mannaioni, G., & Amedei, A. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906215 · Cited by 3
Fernandez, D. E. R., & Peters, B. (2023) · Journal of Substance Use · doi:10.1080/14659891.2023.2261033 · Cited by 2
Borruto, A. M., Calpe-López, C., Spanagel, R., & Bernardi, R. E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110081 · Cited by 2
de Dios, C., Suchting, R., Green, C. E., Webber, H. E., Moeller, F. G., Lane, S. D., & Schmitz, J. M. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2420773 · Cited by 2
Psychometric investigation of the avoidance and inflexibility scale (AIS) for cocaine use
Jo, D., Leonard, S. J., Bodalski, E. A., Schmitz, J. M., & Stotts, A. L. (2025) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2025.100902 · Cited by 2
Rossi, E. D., Pérez, L. J. G., Cardullo, S., Carbone, G. A., Zaffaina, G. C., Farina, B., Terraneo, A., Massullo, C., Imperatori, C., & Gallimberti, L. (2025) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.24-00441 · Cited by 2
Porras-Perales, Ó., Sánchez‐Marín, L., Vera, D. M., Flores-López, M., Martín-Chaves, L., Boccalon, M., Requena-Ocaña, N., García‐Marchena, N., Reviriego, R., Santín, L. J., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111482 · Cited by 2
Sanchez, W. N., Pochapski, J. A., Morrow, A. L., Andreatini, R., Robinson, D. L., Schwarting, R. K. W., Ferré, S., & Cunha, C. D. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110680 · Cited by 2
Quality-of-life improvements associated with reductions in cocaine-positive urine drug screens.
Regnier, S. D., Karnik, K. N., Shellenberg, T., Cox, D. H., McLouth, C. J., Hays, L. R., Anderson, D. M., Schmitz, J. M., Havens, J. R., Lile, J. A., et al. (2025) · Psychology of Addictive Behaviors · doi:10.1037/adb0001107 · Cited by 2
Bao, R., Sun, H., Zhang, X., Zhao, Z., Feng, J., & Jiang, W. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1659675 · Cited by 2
Ware, O. D., Geiger, G. R., & Cano, M. T. (2026) · PLOS mental health. · doi:10.1371/journal.pmen.0000337 · Cited by 2
Zhang, M., Wen, D., Gao, W., Chang, L., Zhao, Z., Zou, Y., Zhang, X., Yang, Y., Luo, J., & Zhang, T. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116335 · Cited by 2
Vilapriño, J. J., Clavel, G., Silva, M., Alvarez, E. O., & Ratti, S. G. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100110 · Cited by 2
Spelta, L. E. W., Real, C. C., Bruno, V., Buchpiguel, C. A., Garcia, R. C. T., Torres, L. H., Faria, D. D. P., & Marcourakis, T. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25327 · Cited by 2
Sontheimer, H. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821228-8.00012-3 · Cited by 2
Molecular Imaging Studies in Stimulant Addiction: A Cross-Species Perspective
Jones, J. A., Russell, B., & Dalley, J. W. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_22 · Cited by 2
Padovan‐Hernandez, Y., Rojas, G., Wu, L., & Knackstedt, L. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06270-x · Cited by 2
Schechter, J., Brown, G. W., & Janda, M. (2023) · Mental Health Clinician · doi:10.9740/mhc.2023.02.004 · Cited by 2
Cheng, Y., Justice, A. C., Wang, Z., Li, B., Hancock, D. B., Johnson, E. O., & Xu, K. (2023) · BMC Genomics · doi:10.1186/s12864-023-09661-2 · Cited by 2
Worhunsky, P. D., Mignosa, M. M., Gallezot, J., Pittman, B. P., Nabulsi, N., Stryjewski, A. M., Khave, L. J., Trinko, R., Dileone, R., Carson, R. E., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.028 · Cited by 2
Unuma, K., Wen, S., Aki, T., & Uemura, K. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149201 · Cited by 2
Simpson, S., de Guglielmo, G., Brennan, M., Maturin, L., Peters, G., Jia, H., Wellmeyer, E., Andrews, S., Woods, L. C. S., Palmer, A. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453592 · Cited by 2
Beckett, K. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780197536575.003.0007 · Cited by 2
Wei, H., LeSaint, J. E., Jin, Z., Zhan, C., & Zheng, F. (2024) · Scientific Reports · doi:10.1038/s41598-023-50678-0 · Cited by 1
Disorders Due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_26-1 · Cited by 1
Self-administration acquisition latency predicts locomotor sensitivity to cocaine in male rats
Rakela, S., Sortman, B. W., Gobin, C. M., Hao, S., Caceres-Brun, D., & Warren, B. L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115170 · Cited by 1
Reduced brain connectivity underlying value-based choices and outcomes in stimulant use disorder
Nestor, L. J., Lim, T. V., Robbins, T. W., & Ersche, K. D. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103676 · Cited by 1
Alexander, K., Sharma, A., Fletcher, J. B., Smith, Z., Huddleston, T., Gryczynski, J., & Stitzer, M. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1576277 · Cited by 1
Li, J., Liu, X., Du, X., Mi, T., & Ren, Z. (2025) · Journal of Medical Internet Research · doi:10.2196/77853 · Cited by 1
Shanmugam, S., Arunkumar, S., Agrawal, V., & Kumar, P. (2025) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2025-1117 · Cited by 1
Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice
Bruno, V., Spelta, L. E. W., Pereira, M. L., Dörr, F., Paranhos, B. A. P. B., Santos, F. P., Yonamine, M., Garcia, R. C. T., Torres, L. H., Pasquale, R. D., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06946-0 · Cited by 1
Treatment of Cocaine and Methamphetamine Use Disorders
Wolkowicz, N. R., Schwartz, E. K. C., MacLean, R. R., & Sofuoglu, M. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00704-0 · Cited by 1
Carpenter, M. (2001) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention
Koutrouli, I. R. A., Brejtr, V., Schwendt, M., Witek, K., Charalambous, C., Aleksič, K., Miniariková, N., Lhotková, E., Toman, M., Nikolič, M., et al. (2026) · Addiction Biology · doi:10.1111/adb.70111 · Cited by 1
Disruption of Dopamine Homeostasis by Psychostimulants
Torres, J., Bredenkamp, C., Vazquez, A., & Chivero, E. T. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05769-0 · Cited by 1
Cocaine Use Disorder: Neuropathology and Exploratory Treatments
Almeida, A., Warlick, H., Arain, A., Arora, S., Boldt, E. A., Chandramohan, C., Chandramohan, P., Fogel, M., Gogerdchian, H., Hajivandi, B., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05840-w · Cited by 1
Network intervention analysis of ACT processes in cocaine use disorder
Jo, D., Bodalski, E. A., Leonard, S. J., Masuda, A., Schmitz, J. M., & Stotts, A. L. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210001 · Cited by 1
Dietiker, L., Zacher, A., de’Sperati, S., Loosli, M., Schmid, L. B., Wernigg, M., Rühlmann, C., Bavato, F., Zoelch, N., Seifritz, E., et al. (2026) · European Journal of Psychotraumatology · doi:10.1080/20008066.2026.2650920 · Cited by 1
GPR4 regulates temporally dynamic and sex-dependent cocaine-induced locomotor sensitization
Chai, E. S., Glaser, D., Cascone, J., Brady, G., Bader, A., Cacoulidis, C., Kapoor, A., Yu, E., Chu, Y., Sapkota, S., et al. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1894955 · Cited by 1
Infralimbic pyramidal neurons gate learned suppression of cocaine-conditioned behavior in male mice
Pérez-Cano, A. M., Pérez-Berlanga, J. M., Ávila‐Gámiz, F., Blanco, E., Santín, L. J., & de Guevara‐Miranda, D. L. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111156 · Cited by 1
Cocaine-Induced Ventilation/Perfusion Mismatch Mimicking Pulmonary Embolism
Surapaneni, P. K., Abe, T., & Fas, N. (2020) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709620906962 · Cited by 1
Chapter 11. Treatment of Stimulant-Related Disorders
Rawson, R. A., Schmidt, K., & Mooney, L. J. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb11 · Cited by 1
Sivaprakasam, K., & Hess, G. P. (2021) · The Journal of Membrane Biology · doi:10.1007/s00232-021-00202-0 · Cited by 1
Beckett, K. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780197536575.003.0003 · Cited by 1
Early life substance abuse and epigenetic programming
Leyrer‐Jackson, J. M., Hood, L. E., & Olive, M. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821785-6.00008-6 · Cited by 1
Substance and Prescription Misuse in Military and Veteran Populations
Rachal, J., Schrader, C. C., Schindler, A., & Ridpath, V. (2023) · Springer eBooks · doi:10.1007/978-3-031-18009-5_17 · Cited by 1
Cannabidiol in medicinal usage of stress: Modeling investigations into cocaine
Valverde, O., & García-Fuster, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00035-1 · Cited by 1
Use, Effects, and Diagnostic Challenges of Cocaine Use in “Baby Boomers” and Older Adults
Akwe, J. A., Moussa, M., & Hall, M. A. K. (2023) · Journal of Brown Hospital Medicine · doi:10.56305/001c.87784 · Cited by 1
Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine
Metsch, L. R., Feaster, D. J., Gooden, L. K., Pan, Y., Parish, C. L., Waldrop, D. G., Rodriguez, A. E., Colasanti, J. A., Castellón, P. C., Armstrong, W. S., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf104 · Cited by 1
Fischer, S. K. M., & Mutschler, J. (2025) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2537-9595 · Cited by 1
Ketamine for Treatment of Addiction in Alcohol, Opioid, and Cocaine Use Disorder
Vujović, K. S., Jotic, A. D., Medić, B., & Cirkovic, I. B. (2025) · Neuromethods · doi:10.1007/978-1-0716-4599-4_19 · Cited by 1
Cannabidiol effects on cocaine-seeking behaviour and incubation of craving in micePreprint
Alegre-Zurano, L., Luján, M. Á., Cantacorps, L., Martín‐Sánchez, A., García-Baos, A., & Valverde, O. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.18.423391 · Cited by 1
Stiltner, B., Pietrzak, R. H., Tylee, D. S., Nuñez, Y. Z., Adhikari, K., Kranzler, H. R., Gelernter, J. E., & Polimanti, R. A. (2023) · medRxiv · doi:10.1101/2023.02.08.23285653 · Cited by 1
Characterizing novel allosteric modulators for human dopamine transporter
Yang, F., & Mortensen, O. V. (2024) · iDEA - Drexel University Institutional Repository · doi:10.17918/00010445 · Cited by 1
Murphy, Z. (2023) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
Karsinti, E. (2021) · theses.fr (ABES) · doi:10.70675/5b8100e0z5b52z427cz82a3zc345bcac8d0d · Cited by 1
Metadata
- Authors
- Kampman, K. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kampman, Kyle M.
- ORCID
- Kampman, Kyle M.
- Venue
- Science Advances
- Published
- 2019-10-11
- Volume
- 5
- Issue
- 10
- Pages
- eaax1532-eaax1532
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6795516
- OpenAlex
- W2981018657
- Cited by
- 250
- References
- 71
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 43 · 2023: 41 · 2022: 47 · 2021: 28 · 2020: 12
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- cocaine dependence, cocaine addiction treatment, psychosocial interventions, contingency management, cognitive behavioral therapy, drug augmentation, dopamine agonists, modafinil, topiramate, glutamatergic agents, GABAergic agents, combination drugs
- MeSH terms
- Animals, Cocaine, Humans, United States, Dopamine Agonists, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.